NCT01701323View on ClinicalTrials.gov

Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 10, 2012

Primary Completion Date

May 10, 2018

Study Completion Date

May 10, 2018

Conditions
Acute Leukemia of Ambiguous LineageAcute Myeloid Leukemia
Interventions
BIOLOGICAL

Ex-Vivo Expanded Cord Blood Progenitor Cell Infusion

Given IV

DRUG

Cytarabine

Given IV

DRUG

Filgrastim

Given SC or IV

DRUG

Fludarabine Phosphate

Given IV

Trial Locations (2)

30322

Emory University/Winship Cancer Institute, Atlanta

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Fred Hutchinson Cancer Center

OTHER

lead

Nohla Therapeutics, Inc.

INDUSTRY